Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by meunierwilberton Sep 07, 2021 3:39pm
147 Views
Post# 33819988

Reducing Risks with Non-Burning Devices

Reducing Risks with Non-Burning Devices
Sponsored post. As there might be no combustion in vaping, there could also be no smoke produced. That's why these heat not burn pod devices seems to have really capture the attention of the smoking masses! Thinking about making the transition to these non smoking systems? Worry no more, cause these puffing insight got it in the bag for you!!
 
Heat-not-burn (HNB) tobacco products are said to emit aerosols containing nicotine and other compounds that could be breathed via the mouth by users. They also contain non-tobacco additives, and are often flavoured. HNB tobacco products could mimic the behaviour of smoking conventional cigarettes, and some might also make use of specifically designed cigarettes to contain the tobacco for heating.
 
Some tobacco industry-funded studies have claimed that there could be significant reductions in the formation of and exposure to harmful and potentially harmful constituents relative to standard cigarettes. However, there might be no current evidence to suggest that reduced exposure to these chemicals could also translate to reduced risk in humans. Therefore, additional independent studies might be required to substantiate claims of reduced risk/harm. Check disclaimer on profile and landing page.
<< Previous
Bullboard Posts
Next >>